Skip to main content
Premium Trial:

Request an Annual Quote

Microbix Biosystems, SDT Molecular Ink Distribution Deal for Quality Assessment Products

NEW YORK ─ Microbix Biosystems said on Monday that it has inked an agreement that enables SDT Molecular to distribute Microbix's quality assessment products, or QAPs, in Hong Kong, Indonesia, Malaysia, and Singapore.

Under the agreement, SDT will provide customer service, sales and marketing, distribution, and logistical support for Microbix's QAPs.

Financial and other terms of the agreement were not disclosed.

Singapore-based SDT provides products to hospitals and clinical laboratories, has a “strong track record in molecular diagnostics” involving a focus on infectious and genetic diseases, and has experience in product development, manufacturing, distribution, and customer support, Microbix said.

Mississauga, Ontario-based Microbix said it provides more than 70 quality assessment products to support the accuracy of infectious disease diagnostic tests. SDT is particularly interested in its QAPs used to support the accuracy of SARS-CoV-2 molecular and antigen tests as well as tests for the human papilloma virus and Mycoplasma genitalium, Microbix said.

Microbix has also added QAPs to support the accuracy of RT-PCR tests for the Brazilian, South African, and UK SARS-CoV-2 variants of concern.

"With the recent COVID-19 pandemic, we have seen and foresee growing demand in quality control reagents for infectious diseases, especially as more diagnostic laboratories and manufacturers are being established," Tan Shirley, founder and CEO of SDT, said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.